Online Only Articles

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
Public Health Sciences Division, Fred Hutchinson Cancer Research Center
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Medical Oncology, University of Washington
Department of Medicine, Division of Hematology, University of Washington;Seattle Cancer Care Alliance
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
Seattle Cancer Care Alliance
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
Department of Medicine, Division of Hematology, University of Washington
Deparment of Pharmacy Services, University of Washington
Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington
Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington;Department of Medicine, Division of Hematology, University of Washington;Department of Epidemiology, University of Washington, Seattle, WA, USA
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.204792